<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.wjso.com/feeds/latestarticles/journal?quantity=&amp;format=rss&amp;version=">
        <title>World Journal of Surgical Oncology - Latest Articles</title>
        <link>http://www.wjso.com</link>
        <description>The latest research articles published by World Journal of Surgical Oncology</description>
        <dc:date>2009-06-30T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.wjso.com/content/7/1/57" />
                                <rdf:li rdf:resource="http://www.wjso.com/content/7/1/56" />
                                <rdf:li rdf:resource="http://www.wjso.com/content/7/1/55" />
                                <rdf:li rdf:resource="http://www.wjso.com/content/7/1/54" />
                                <rdf:li rdf:resource="http://www.wjso.com/content/7/1/53" />
                                <rdf:li rdf:resource="http://www.wjso.com/content/7/1/52" />
                                <rdf:li rdf:resource="http://www.wjso.com/content/7/1/51" />
                                <rdf:li rdf:resource="http://www.wjso.com/content/7/1/50" />
                                <rdf:li rdf:resource="http://www.wjso.com/content/7/1/49" />
                                <rdf:li rdf:resource="http://www.wjso.com/content/7/1/48" />
                            </rdf:Seq>
        </items>
        <extra:info rdf:parseType="Literal">
            <html:div style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif" xmlns:html="http://www.w3.org/1999/xhtml">
                <html:span style="font-weight:bold">
                    This is an RSS newsfeed from BioMed Central
                </html:span>
                <html:br />
                <html:span style="font-size: 12px;">
                    It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit
                    <html:br />
                    <html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">
                        http://www.biomedcentral.com/info/about/rss/
                    </html:a>
                    <html:br />
                </html:span>
            </html:div>
        </extra:info>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.wjso.com/content/7/1/57">
        <title>Spontaneous pneumothorax as a first sign of pulmonary carcinoma

</title>
        <description>Background:
Spontaneous pneumothorax (SP) is a rare manifestation of lung cancer. The mechanisms by which pneumothorax occurs in lung cancer is not clear, resulting in different views being expressed.Case presentationHere we present a case in which pneumothorax occurred as a first manifestation of lung cancer. The chest x-ray of a 68 year old man revealed a right partial pneumothorax. VATS was then performed: the visceral pleura lying over segment S3 was destroyed and air leaks were found in this section. Pathologic examination of the biopsy specimen revealed non-small cell carcinoma. Thoracoscopic talc pleurodesis was performed.
Conclusions:
Spontaneous pneumothorax in association with lung cancer is rarely seen. Pneumothorax can be the first sign of lung cancer. The most common possibility for SP complicating lung cancer is the tumor necrosis mechanism or, in separate cases, rupture of the emphysematous bullae. Lung cancer should always be considered as a possible cause of SP in elderly patients or in heavy smokers.</description>
        <link>http://www.wjso.com/content/7/1/57</link>
                <dc:creator>Vladislavas Vencevicius</dc:creator>
                <dc:creator>Saulius Cicenas</dc:creator>
                <dc:source>World Journal of Surgical Oncology 2009, 7:57</dc:source>
        <dc:date>2009-06-30T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-7819-7-57</dc:identifier>
        <prism:publicationName>World Journal of Surgical Oncology</prism:publicationName>
        <prism:issn>1477-7819</prism:issn>
        <prism:volume>7</prism:volume>
        <prism:startingPage>57</prism:startingPage>
        <prism:publicationDate>2009-06-30T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.wjso.com/content/7/1/56">
        <title>Leiomyosarcoma of the inferior vena cava: Radical surgery and vascular reconstruction</title>
        <description>Background:
Vascular leiomyosarcoma are rare tumors typically originating from the inferior vena cava (IVC). Due to nonspecific clinical signs most tumors are diagnosed at advanced stages. Complete surgical resection remains the only potential curative therapeutic option. Surgical strategy is particularly influenced by the level of the IVC affected. Due to the topographic relation to the renal veins level-II involvement of the IVC raises special surgical challenges with respect to the maintenance of venous outflow.Case presentationWe herein report two cases of leiomyosarcoma of the IVC with successful en bloc resection and individualized caval reconstruction. One patient presented with a large intramural and intraluminal mass and received a complete circumferential resection. Reconstruction was performed by graft replacement of the caval segment affected. The other patient displayed a predominantly extraluminal tumor growth and underwent semicircumferential resection of the IVC including the confluence of the left renal vein. In this case vascular reconstruction was performed by cavoplasty and reinsertion of the left renal vein into the proximal portion of the IVC. Resection margins of both patients were tumor free and no clinical signs of venous insufficiency of the lower extremity occurred.
Conclusions:
This paper presents two cases of successfully managed leiomyosarcomas of the vena cava and exemplifies two different options for vascular reconstruction in level II sarcomas and includes a thorough review of the literature.</description>
        <link>http://www.wjso.com/content/7/1/56</link>
                <dc:creator>Andrea Alexander</dc:creator>
                <dc:creator>Alexander Rehders</dc:creator>
                <dc:creator>Andreas Raffel</dc:creator>
                <dc:creator>Christopher Poremba</dc:creator>
                <dc:creator>Wolfram Knoefel</dc:creator>
                <dc:creator>Claus Eisenberger</dc:creator>
                <dc:source>World Journal of Surgical Oncology 2009, 7:56</dc:source>
        <dc:date>2009-06-26T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-7819-7-56</dc:identifier>
        <prism:publicationName>World Journal of Surgical Oncology</prism:publicationName>
        <prism:issn>1477-7819</prism:issn>
        <prism:volume>7</prism:volume>
        <prism:startingPage>56</prism:startingPage>
        <prism:publicationDate>2009-06-26T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.wjso.com/content/7/1/55">
        <title>Primary hepatic embryonal sarcoma masquerading as metastatic ovarian cancer</title>
        <description>Background:
Hepatic embryonal sarcoma (HES) is a rare but aggressive primary tumor of the liver occurring most frequently in childhood.Case presentationWe report a case of a 52 year old woman having previously undergone treatment for ovarian serous papillary carcinoma who subsequently presented with a large solitary mass in the liver. Initially this was presumed to be metastasis from the ovarian primary however, on further examination it was shown to be a primary hepatic embryonal sarcoma.
Conclusion:
Primary liver tumors should be considered in differential diagnoses in patients with ovarian cancer who subsequently present with liver tumors. This is particularly important when there is no direct evidence of recurrence of ovarian cancer.</description>
        <link>http://www.wjso.com/content/7/1/55</link>
                <dc:creator>Peter Kullar</dc:creator>
                <dc:creator>Christopher Stonard</dc:creator>
                <dc:creator>Neville Jamieson</dc:creator>
                <dc:creator>Emmanuel Huguet</dc:creator>
                <dc:creator>Raaj Praseedom</dc:creator>
                <dc:creator>Asif Jah</dc:creator>
                <dc:source>World Journal of Surgical Oncology 2009, 7:55</dc:source>
        <dc:date>2009-06-23T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-7819-7-55</dc:identifier>
        <prism:publicationName>World Journal of Surgical Oncology</prism:publicationName>
        <prism:issn>1477-7819</prism:issn>
        <prism:volume>7</prism:volume>
        <prism:startingPage>55</prism:startingPage>
        <prism:publicationDate>2009-06-23T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.wjso.com/content/7/1/54">
        <title>Ectopic pancreatic-type malignancy presenting in a Meckel&apos;s diverticulum: a case report and review of the literature</title>
        <description>Background:
Neoplasms arising from Meckel&apos;s diverticulae reported in the literature are mainly carcinoid tumours, gastrointestinal stromal tumours, and gastric or intestinal adenocarcinomas.Case presentationWe describe a 50-year-old man who presented with rectal bleeding and anaemia, later found to be caused by a pancreatic adenocarcinoma arising from ectopic pancreatic tissue in a Meckel&apos;s diverticulum. The tumour was unfortunately highly aggressive, and the patient passed away within 5 months of symptom onset.
Conclusion:
We believe this is the first case of pancreatic adenocarcinoma in a Meckel&apos;s diverticulum to be reported in the literature. The diagnosis of Meckel&apos;s should be considered in patients with acute gastrointestinal complaints; when found incidentally at laparotomy, it should be carefully examined for any gross abnormality and resection should be considered.</description>
        <link>http://www.wjso.com/content/7/1/54</link>
                <dc:creator>Hoey Koh</dc:creator>
                <dc:creator>Blaithin Page</dc:creator>
                <dc:creator>Catherine Black</dc:creator>
                <dc:creator>Ian Brown</dc:creator>
                <dc:creator>Stuart Ballantyne</dc:creator>
                <dc:creator>David Galloway</dc:creator>
                <dc:source>World Journal of Surgical Oncology 2009, 7:54</dc:source>
        <dc:date>2009-06-22T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-7819-7-54</dc:identifier>
        <prism:publicationName>World Journal of Surgical Oncology</prism:publicationName>
        <prism:issn>1477-7819</prism:issn>
        <prism:volume>7</prism:volume>
        <prism:startingPage>54</prism:startingPage>
        <prism:publicationDate>2009-06-22T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.wjso.com/content/7/1/53">
        <title>Spontaneous regression in alveolar soft part sarcoma:
case report and literature review

</title>
        <description>Background:
Sarcomas are a type of malignant tumors that arise from connective tissue. They are most of the time found in extremitiesCase presentationWe are presenting a case of adult male patient, who was found to have huge abdominal mass and multiple gastric and duodenal polyps. Pathological diagnosis for all lesions was Alveolar soft part sarcoma. Although he complained from metastasis to both lungs and right atrium, all these deposits regressed spontaneously. Patient stated that he used some herbs (Teucrium polium, Cat Thyme) prescribed for him. No chemotherapy or radiotherapy was given. The duration of regression was about 5 months before other lesions appeared. Later on, he died secondary to brain metastasis.
Conclusion:
ASPS is a rare type of sarcomas that affect primarily the lower limbs. This tumor does rarely metastasize to the gastrointestinal tract.</description>
        <link>http://www.wjso.com/content/7/1/53</link>
                <dc:creator>Mohammed BaniHani</dc:creator>
                <dc:creator>Abdel Rahman Al Manasra</dc:creator>
                <dc:source>World Journal of Surgical Oncology 2009, 7:53</dc:source>
        <dc:date>2009-06-10T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-7819-7-53</dc:identifier>
        <prism:publicationName>World Journal of Surgical Oncology</prism:publicationName>
        <prism:issn>1477-7819</prism:issn>
        <prism:volume>7</prism:volume>
        <prism:startingPage>53</prism:startingPage>
        <prism:publicationDate>2009-06-10T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.wjso.com/content/7/1/52">
        <title>Surgical treatment for locally advanced lower third rectal cancer after neoadjuvent chemoradiation with capecitabine: prospective phase II trial </title>
        <description>IntroductionTreatment of rectal cancer requires a multidisciplinary approach with standardized surgical, pathological and radiotherapeutic procedures. Sphincter preserving surgery for cancer of the lower rectum needs a long-course of neoadjuvant treatments to reduce tumor volume, to induce down-staging that increases circumferential resection margin, and to facilitate surgery.AimTo evaluate the rate of anal sphincter preservation in low lying, resectable, locally advanced rectal cancer and the resectability rate in unresectable cases after neoadjuvent chemoradiation by oral Capecitabine.Patients and methodsThis trial included 43 patients with low lying (4&#8211;7 cm from anal verge) locally advanced rectal cancer, of which 33 were resectable. All patients received preoperative concurrent chemoradiation (45 Gy/25 fractions over 5 weeks with oral capecitabine 825 mg/m2 twice daily on radiotherapy days), followed after 4&#8211;6 weeks by total mesorectal excision technique.
Results:
Preoperative chemoradiation resulted in a complete pathologic response in 4 patients (9.3%; 95% CI 3&#8211;23.1) and an overall downstaging in 32 patients (74.4%; 95% CI 58.5&#8211;85). Sphincter sparing surgical procedures were done in 20 out of 43 patients (46.5%; 95% CI 31.5&#8211;62.2). The majority (75%) were of clinical T3 disease. Toxicity was moderate and required no treatment interruption. Grade II anemia occurred in 4 patients (9.3%, 95% CI 3&#8211;23.1), leucopenia in 2 patients (4.7%, 95% CI 0.8&#8211;17) and radiation dermatitis in 4 patients (9.3%, 95% CI 3&#8211;23.1) respectively.
Conclusion:
In patients with low lying, locally advanced rectal cancer, preoperative chemoradiation using oral capecitabine 825 mg/m2, twice a day on radiotherapy days, was tolerable and effective in downstaging and resulted in 46.5% anal sphincter preservation rate.</description>
        <link>http://www.wjso.com/content/7/1/52</link>
                <dc:creator>Mostafa Abd Elwanis</dc:creator>
                <dc:creator>Doaa Maximous</dc:creator>
                <dc:creator>Mohamed Ibrahim Elsayed</dc:creator>
                <dc:creator>Nabiel Mikhail</dc:creator>
                <dc:source>World Journal of Surgical Oncology 2009, 7:52</dc:source>
        <dc:date>2009-06-09T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-7819-7-52</dc:identifier>
        <prism:publicationName>World Journal of Surgical Oncology</prism:publicationName>
        <prism:issn>1477-7819</prism:issn>
        <prism:volume>7</prism:volume>
        <prism:startingPage>52</prism:startingPage>
        <prism:publicationDate>2009-06-09T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.wjso.com/content/7/1/51">
        <title>Incidence of synchronous appendiceal neoplasm in patients with colorectal cancer and its clinical significance</title>
        <description>Background:
The aims of this study were to evaluate the incidence of synchronous appendiceal neoplasm in patients with colorectal cancer, and to determine its clinical significance.
Methods:
Pathological reports and medical records were reviewed of patients with colorectal adenocarcinoma who underwent oncological resection of the tumor together with appendectomy at the Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand between September 2000 and April 2008.
Results:
This study included 293 patients with an average age of 62 years (range 19&#8211;95) and 51 percent were male. Of the patients studied, 228 (78 percent) had right hemicolectomy, whereas the others (22 percent) had surgery for left-sided colon cancer or rectal cancer. One patient (0.3 percent) had epithelial appendiceal neoplasm (mucinous cystadenoma) and 3 patients (1.0 percent) had metastatic colorectal cancer in the mesoappendix. However, the presence of synchronous appendiceal tumors and/or metastasis did not alter postoperative management, as these patients had received adjuvant therapy and were scheduled for surveillance program because of nodal involvement.
Conclusion:
The incidence of synchronous primary appendiceal neoplasm and secondary (metastatic) appendiceal neoplasm in colorectal cancer patients was 0.3 and 1.0 percent, respectively. However, these findings did not change the postoperative clinical management.</description>
        <link>http://www.wjso.com/content/7/1/51</link>
                <dc:creator>Varut Lohsiriwat</dc:creator>
                <dc:creator>Akkrarash Vongjirad</dc:creator>
                <dc:creator>Darin Lohsiriwat</dc:creator>
                <dc:source>World Journal of Surgical Oncology 2009, 7:51</dc:source>
        <dc:date>2009-06-02T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-7819-7-51</dc:identifier>
        <prism:publicationName>World Journal of Surgical Oncology</prism:publicationName>
        <prism:issn>1477-7819</prism:issn>
        <prism:volume>7</prism:volume>
        <prism:startingPage>51</prism:startingPage>
        <prism:publicationDate>2009-06-02T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.wjso.com/content/7/1/50">
        <title>Ruptured gallbladder as the first presentation of breast cancer</title>
        <description>Background:
Perforation of the gall bladder as a first presentation of breast cancer has not been reported.Case presentationHere we present a case of an elderly lady with acute abdomen with evidence of possible perforation of gall bladder on CT scan. Histopathology of the cholecystectomy specimen revealed invasive lobular breast cancer.Her metastatic breast cancer with right sided primary discovered subsequent to her presentation with acute abdomen is managed successfully with Anastrozole.
Conclusion:
We present a rare case of gall bladder perforation from metastatic breast cancer.</description>
        <link>http://www.wjso.com/content/7/1/50</link>
                <dc:creator>M Jones</dc:creator>
                <dc:creator>J Mathew</dc:creator>
                <dc:creator>Ke Abdullah</dc:creator>
                <dc:creator>T McCulloch</dc:creator>
                <dc:creator>Kl Cheung</dc:creator>
                <dc:source>World Journal of Surgical Oncology 2009, 7:50</dc:source>
        <dc:date>2009-06-01T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-7819-7-50</dc:identifier>
        <prism:publicationName>World Journal of Surgical Oncology</prism:publicationName>
        <prism:issn>1477-7819</prism:issn>
        <prism:volume>7</prism:volume>
        <prism:startingPage>50</prism:startingPage>
        <prism:publicationDate>2009-06-01T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.wjso.com/content/7/1/49">
        <title>The combination effect of sodium butyrate and 5-Aza-2&apos;-deoxycytidine on radiosensitivity in RKO colorectal cancer and MCF-7 breast cancer cell lines</title>
        <description>Background:
The overall level of chromatin compaction is an important mechanism of radiosensitivity, and modification of DNA methylation and histone deacetylation may increase radiosensitivity by altering chromatin compaction. In this study, we investigated the effect of a demethylating agent, a histone deacetylase(HDAC) inhibitor, and the two agents combined on radiosensitivity in human colon and breast cancer cell lines.
Methods:
In this study, we used RKO colorectal cancer cell line and MCF-7 breast cancer cell lines and normal colon cell lines. On each of the cell lines, we used three different agents: the HDAC inhibitor sodium butyrate(SB), the demethylating agent 5-Aza-2&apos;-deoxycytidine(5-aza-DC), and radiation. We then estimated the percentage of the cell survival using the XTT method and experimented to determine if there was an augmentation in the therapeutic effect by using different combinations of the two or three of the treatment methods.
Results:
After treatment of each cell lines with 5-aza-DC, SB and 6 grays of radiation, we observed that the survival fraction was lower after the treatment with 5-aza-DC or SB than with radiation alone in RKO and MCF-7 cell lines(p &lt; 0.001). The survival fraction was lowest when the two agents, 5-aza-DC and SB were combined with radiation in both RKO and MCF-cell lines.
Conclusion:
In conclusion, 5-aza-DC and SB can enhance radiosensitivity in both MCF-7 and RKO cell lines. The combination effect of a demethylating agent and an HDAC inhibitor is more effective than that of single agent treatment in both breast and colon cancer cell lines.</description>
        <link>http://www.wjso.com/content/7/1/49</link>
                <dc:creator>Hang Joo Cho</dc:creator>
                <dc:creator>Sin Young Kim</dc:creator>
                <dc:creator>Kee Hwan Kim</dc:creator>
                <dc:creator>Won Kyung Kang</dc:creator>
                <dc:creator>Ji Il Kim</dc:creator>
                <dc:creator>Seong Tack Oh</dc:creator>
                <dc:creator>Jeong Soo Kim</dc:creator>
                <dc:creator>Chang Hyeok An</dc:creator>
                <dc:source>World Journal of Surgical Oncology 2009, 7:49</dc:source>
        <dc:date>2009-05-21T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-7819-7-49</dc:identifier>
        <prism:publicationName>World Journal of Surgical Oncology</prism:publicationName>
        <prism:issn>1477-7819</prism:issn>
        <prism:volume>7</prism:volume>
        <prism:startingPage>49</prism:startingPage>
        <prism:publicationDate>2009-05-21T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.wjso.com/content/7/1/48">
        <title>Management of appendiceal pseudomyxoma peritonei diagnosed during pregnancy</title>
        <description>Background:
The incidence of cancer during pregnancy is approximately 1 in 1000. The most common types encountered during pregnancy are cervical, breast and ovarian. Epithelial tumors of the appendix on the other hand are rare and account for only approximately 1% of all colorectal neoplasms; the occurrence of this neoplasm during pregnancy is extremely rare.Case PresentationThe medical history of a 30 year old woman diagnosed at 17 weeks gestation with an appendiceal mucinous tumor with large volume pseudomyxoma peritonei was presented. Her pregnancy was preserved and she had an early vaginal delivery of a healthy baby at 35 weeks. At 2 1/2 weeks postpartum the patient underwent extensive cytoreductive surgery and intraperitoneal chemotherapy. She remains disease-free 5 years after her initial diagnosis. A literature review of this clinical situation and a discussion of treatment plans were presented.
Conclusion:
The management of an appendiceal tumor with pseudomyxoma peritonei diagnosed during pregnancy requires full knowledge of the natural history of this disease to achieve a balance of concern for maternal survival and fetal health.</description>
        <link>http://www.wjso.com/content/7/1/48</link>
                <dc:creator>Erika Haase</dc:creator>
                <dc:creator>Dal Yoo</dc:creator>
                <dc:creator>Paul Sugarbaker</dc:creator>
                <dc:source>World Journal of Surgical Oncology 2009, 7:48</dc:source>
        <dc:date>2009-05-19T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-7819-7-48</dc:identifier>
        <prism:publicationName>World Journal of Surgical Oncology</prism:publicationName>
        <prism:issn>1477-7819</prism:issn>
        <prism:volume>7</prism:volume>
        <prism:startingPage>48</prism:startingPage>
        <prism:publicationDate>2009-05-19T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>
